These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15545509)

  • 1. Pulse pressure and coronary atherosclerosis progression in postmenopausal women.
    Nair GV; Waters D; Rogers W; Kowalchuk GJ; Stuckey TD; Herrington DM
    Hypertension; 2005 Jan; 45(1):53-7. PubMed ID: 15545509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
    Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D
    N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
    Waters DD; Alderman EL; Hsia J; Howard BV; Cobb FR; Rogers WJ; Ouyang P; Thompson P; Tardif JC; Higginson L; Bittner V; Steffes M; Gordon DJ; Proschan M; Younes N; Verter JI
    JAMA; 2002 Nov; 288(19):2432-40. PubMed ID: 12435256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance.
    Howard BV; Hsia J; Ouyang P; Van Voorhees L; Lindsay J; Silverman A; Alderman EL; Tripputi M; Waters DD
    Circulation; 2004 Jul; 110(2):201-6. PubMed ID: 15226212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
    Patel D; Ahmad S; Silverman A; Lindsay J
    Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.
    Hodis HN; Mack WJ; Azen SP; Lobo RA; Shoupe D; Mahrer PR; Faxon DP; Cashin-Hemphill L; Sanmarco ME; French WJ; Shook TL; Gaarder TD; Mehra AO; Rabbani R; Sevanian A; Shil AB; Torres M; Vogelbach KH; Selzer RH;
    N Engl J Med; 2003 Aug; 349(6):535-45. PubMed ID: 12904518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
    Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
    JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.
    Herrington DM; Reboussin DM; Klein KP; Sharp PC; Shumaker SA; Snyder TE; Geisinger KR
    Control Clin Trials; 2000 Jun; 21(3):257-85. PubMed ID: 10822123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.
    Yeboah J; Reboussin DM; Waters D; Kowalchuk G; Herrington DM
    Am Heart J; 2007 Mar; 153(3):439-44. PubMed ID: 17307425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of progression of coronary calcium in postmenopausal women on versus not on estrogen/progestin therapy.
    Becker A; Leber A; von Ziegler F; Becker C; Knez A
    Am J Cardiol; 2007 Feb; 99(3):374-8. PubMed ID: 17261401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women.
    Hayward CS; Samaras K; Campbell L; Kelly RP
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):699-703. PubMed ID: 11465656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Barnabei VM; Phillips TM; Hsia J
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1167-72. PubMed ID: 10595329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.
    Nair GV; Chaput LA; Vittinghoff E; Herrington DM;
    Chest; 2005 May; 127(5):1498-506. PubMed ID: 15888820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study.
    Grady D; Yaffe K; Kristof M; Lin F; Richards C; Barrett-Connor E
    Am J Med; 2002 Nov; 113(7):543-8. PubMed ID: 12459399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.
    Hlatky MA; Boothroyd D; Vittinghoff E; Sharp P; Whooley MA;
    JAMA; 2002 Feb; 287(5):591-7. PubMed ID: 11829697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status.
    Lamon-Fava S; Herrington DM; Horvath KV; Schaefer EJ; Asztalos BF
    Metabolism; 2010 Dec; 59(12):1794-800. PubMed ID: 20580029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.